Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02701582 · ClinicalTrials.gov registry record · NA
Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT02701582 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 66 participants.
The verdict
NCT02701582, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a prospective, randomized controlled trial to determine if using FloTrac/EV1000 system in neurosurgical patients undergoing craniotomies for aneurysm repair or tumor resection complicated by cerebral edema, or complex spinal surgery including multi-level scoliosis correction, is a more effective way of monitoring fluid.
Interventions
- DRUG Epinephrine
- OTHER Normal Saline
- DRUG Phenylephrine
- OTHER Albumin
- OTHER Voluven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02701582
The ClinicalTrials.gov registry entry for NCT02701582 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Epinephrine is the first listed.
NCT02701582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02701582 about?
NCT02701582 is a clinical study titled "Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients". This is a prospective, randomized controlled trial to determine if using FloTrac/EV1000 system in neurosurgical patients undergoing craniotomies for aneurysm repair or tumor resection complicated by cerebral edema, or complex spinal surgery including multi-level scoliosis correction, is a more effec...
What is the current status of trial NCT02701582?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2014-03. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02701582?
The interventions under investigation include: Epinephrine (DRUG), Normal Saline (OTHER), Phenylephrine (DRUG), Albumin (OTHER), Voluven (OTHER).
Who is sponsoring clinical trial NCT02701582?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.